N-(chloroacetyl)-1-methyl-4-(morpholin-4-ylsulfonyl)-1H-pyrrole-2-carboxamide
Names and Identifiers of 1000932-87-5
CAS Number |
1000932-87-5 |
|---|---|
MDL Number |
MFCD09863411 |
IUPAC Name |
N-(2-chloroacetyl)-1-methyl-4-morpholin-4-ylsulfonylpyrrole-2-carboxamide |
InChI |
InChI=1S/C12H16ClN3O5S/c1-15-8-9(6-10(15)12(18)14-11(17)7-13)22(19,20)16-2-4-21-5-3-16/h6,8H,2-5,7H2,1H3,(H,14,17,18) |
InChIKey |
NPNTTXBIIUFHFT-UHFFFAOYSA-N |
Canonical SMILES |
CN1C=C(C=C1C(=O)NC(=O)CCl)S(=O)(=O)N2CCOCC2 |
UNSPSC Code |
12352100 |
Physical and chemical properties of 1000932-87-5
Acidity coefficient |
9.79±0.46(Predicted) |
|---|---|
Density |
1.55 ± 0.1 g/cm3(Predicted) |
Exact Mass |
349.049927 |
H Bond Acceptors |
5 |
H Bond Donors |
1 |
Index of Refraction |
n20D1.64 ± 0.05(Predicted) |
LogP |
-1.26 |
Molecular Formula |
C12H16N3O5SCl |
Molecular Weight |
349.79 |
Safety Information of 1000932-87-5
Applications of 1000932-87-5
N-(2-chloroacetyl)-1-methyl-4-(morpholine-4-sulfonyl)-1H-pyrrole-2-carboxamide has a wide range of applications across various fields:
- Chemical Research: Serves as a building block for synthesizing more complex molecules.
- Biological Studies: Investigated for potential roles as enzyme inhibitors or receptor modulators.
- Medical
Interaction Studies of 1000932-87-5
Studies on the interactions of N-(2-chloroacetyl)-1-methyl-4-(morpholine-4-sulfonyl)-1H-pyrrole-2-carboxamide with biological systems are ongoing. Preliminary findings suggest that its unique functional groups may enhance solubility and biological interactions, making it a valuable compound for further research in pharmacology and biochemistry.
Biological Activity of 1000932-87-5
Research indicates that N-(2-chloroacetyl)-1-methyl-4-(morpholine-4-sulfonyl)-1H-pyrrole-2-carboxamide exhibits promising biological activity, particularly in the areas of antimicrobial and anticancer properties. Its structural features suggest potential as an enzyme inhibitor or receptor modulator, making it a candidate for further therapeutic exploration.
